endostatin/angiostatin (Gencell)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameendostatin/angiostatin (Gencell)

Drug Alias Nameendostatin/angiotensin (Centelion)

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector

Mechanisms of ActionEndostatin modulators

TargetsEndostatin

Therapy Area/IndicationsAngiogenesis disorderNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCentelion SAS

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesCentelion SAS

Active IndicationsN/A

Inactive IndicationsAngiogenesis disorderNeoplasms

ATC CodeN/A